PCVX: Vaxcyte, Inc. Stock

by  •  • Comments Off on PCVX: Vaxcyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,017.19
Enterprise Value ($M) 3,670.34
Book Value ($M) 3,200.03
Book Value / Share 24.81
Price / Book 1.26
NCAV ($M) 1,538.49
NCAV / Share 11.93
Price / NCAV 2.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 17.70
Current Ratio 17.70

Balance Sheet (mrq) ($M)
Current Assets 1,716.56
Assets 3,378.10
Liabilities 178.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -569.55
Net Income -463.93

Cash Flow Statement (mra) ($M)
Cash From Operations -452.63
Cash from Investing -2,005.67
Cash from Financing 2,448.51

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Janus Henderson Group Plc 11.30 37.49
04-17 13G/A BlackRock, Inc. 7.60 14.58
02-12 13G/A Fmr Llc 10.50 -17.10
11-14 13G/A Ra Capital Management, L.p. 9.99 30.61

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 255,440 1,643,031 15.55
2025-05-08 711,195 2,704,188 26.30
2025-05-07 322,987 2,628,891 12.29
2025-05-06 1,244,962 4,256,661 29.25
2025-05-05 367,372 1,180,602 31.12

(click for more detail)

Similar Companies
OVID – Ovid Therapeutics Inc. PBYI – Puma Biotechnology, Inc.
PCRX – Pacira BioSciences, Inc. PEPG – PepGen Inc.
PGEN – Precigen, Inc.


Financial data and stock pages provided by
Fintel.io